Ledger.Open graph →

SEC Form D · Amendment · filed November 21, 2018

Inozyme Pharma, Inc

Offering

$48.9M

Sold

$48.9M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

BOSTON, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Axel Bolte · Boston, MAExec · Director Reinaldo Diaz · Boston, MADirector Rob Hopfner · Boston, MADirector Joseph Schlessinger · Boston, MAExec · Director Edward Mathers · Boston, MADirector Martin Edwards · Boston, MADirector William Bennett · Chicago, ILExec · Director Robert Saunders · Chicago, ILDirector Matthew Goebel · Chicago, ILDirector Michael J. Hughes · Evanston, ILExec · Director Daniel J. Hopkins · Evanston, ILDirector Andrew Denardo · Red Bank, NJDirector Eric Huebner · Indianapolis, INDirector Sean Mullins · Indianapolis, INDirector Sean Lavies · Indianapolis, INExec · Director Harley Miller · Brooklyn, NYDirector GGV Discovery II L.L.C · Menlo Park, CAExec · Director Robert D. Ghiselli · Glendale, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗